Literature DB >> 1676236

Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.

A N Orekhov1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676236     DOI: 10.1007/bf01983339

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  5 in total

1.  Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.

Authors:  A N Orekhov; G N Baldenkov; V V Tertov; L H Ryong; S G Kozlov; A A Lyakishev; V A Tkachuk; V N Smirnov
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

2.  Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.

Authors:  A N Orekhov; V V Tertov; K A Khashimov; S S Kudryashov; V N Smirnov
Journal:  Am J Cardiol       Date:  1987-02-15       Impact factor: 2.778

3.  In vitro models of anti-atherosclerotic effects of cardiovascular drugs.

Authors:  A N Orekhov
Journal:  Am J Cardiol       Date:  1990-12-18       Impact factor: 2.778

4.  Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.

Authors:  A N Orekhov; V V Tertov; S A Kudryashov; Kh A Khashimov; V N Smirnov
Journal:  Atherosclerosis       Date:  1986-05       Impact factor: 5.162

5.  Antiatherosclerotic effects of calcium antagonists. Study in human aortic cell culture.

Authors:  A N Orekhov; G N Baldenkov; V V Tertov; K A Khashimov; S A Kudryashov; L H Ryong; S G Kozlov; A A Lyakishev; V A Tkachuk
Journal:  Herz       Date:  1990-04       Impact factor: 1.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.